Key deals this week: Merck, Day One Biopharmaceutical, ABN AMRO, Revvity, Centerspace and more (BX:NYSE)

Here’s a list of key deals reported across sectors this week:

Merck (MRK) to acquire Cidara Therapeutics (CDTX) for $221.50 per share in cash, for a total transaction value of approximately $9.2 billion.

Day One Biopharmaceuticals (DAWN) has signed a definitive